Sensus Healthcare (SRTS) Non-Current Debt (2017 - 2021)
Sensus Healthcare's (SRTS) quarterly Non-Current Debt came in at $213000.0 in Q1 2021, down 20.22% quarter-over-quarter from $267000.0 in Q4 2020.
Sensus Healthcare (SRTS) Non-Current Debt (2017 - 2021) Analysis & Trends
Sensus Healthcare's Non-Current Debt history runs 4 years deep, the most recent figure standing at $213000.0 for Q1 2021.
- On a quarterly basis, Non-Current Debt changed N/A year-over-year to $213000.0 in Q1 2021; TTM through Mar 2021 was $213000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $267000.0, changed N/A from the prior year.
- Non-Current Debt eased to $213000.0 in Q1 2021 per SRTS's latest filing, from $267000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $4.2 million in Q1 2018 and bottomed at $213000.0 in Q1 2021.
- The 4-year median for Non-Current Debt is $1.0 million (2020), against an average of $1.9 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Sensus Healthcare | 49.55 Mn | 31.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 213,000.00 |
| Dec 31, 2020 | 267,000.00 |
| Sep 30, 2020 | 1.02 Mn |
| Jun 30, 2020 | 1.02 Mn |
| Jun 30, 2018 | 4.22 Mn |
| Mar 31, 2018 | 4.22 Mn |
| Dec 31, 2017 | 2.21 Mn |